SÜSS MicroTec (SMHN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Record order intake of €410 million in H1 2026, driven by a €115 million coater order in Taiwan and strong demand in Advanced Backend Solutions, more than doubling sales and up 145.8% year-over-year.
Sales declined 23.9% year-over-year to €202.8 million, reflecting a transition year and lower sales in Photomask Solutions, but sequential improvement was seen from Q1 to Q2.
Gross profit margin was 37.2%, slightly above guidance but down 0.8 percentage points year-over-year; EBIT margin was 7.0% for H1, improving to 9% in Q2 but below prior year.
Free cash flow turned positive at €16.4 million, supported by lower CapEx and improved operating cash flow.
Order book reached an all-time high of €476 million as of June 30, 2026, providing strong visibility for 2026 and 2027.
Financial highlights
Net profit for H1 2026 was €8.7 million, down 70.2% year-over-year; EPS basic at €0.46, down 72.9%.
EBITDA for H1 2026 was €21.5 million (margin 10.6%), down 55.3% year-over-year.
Cash and cash equivalents increased to €112.3 million; net cash rose to €63.6 million.
Capital expenditures decreased to €4.6 million, mainly for installations at German sites.
Equity ratio at 59% as of June 30, 2026, with equity at €326.1 million.
Outlook and guidance
Full-year 2026 sales guidance confirmed at €425–485 million, with gross profit margin of 35–38% and EBIT margin of 8–10%.
Approximately €240 million of the order book is expected to convert into sales in H2 2026, with €220 million planned for 2027.
Management expects stronger sales in H2 2026, with most new orders now for 2027.
Risks to the outlook have increased due to geopolitical tensions and supply chain bottlenecks, but no significant project delays are currently assumed.
Latest events from SÜSS MicroTec
- Revenue set to double by 2030, fueled by innovation, service growth, and margin expansion.SMHN
CMD 20259 Jul 2026 - Record sales and profitability in 2024 set a strong outlook for 2025.SMHN
Q4 20248 Jul 2026 - Sales up 45.6%, EBIT margin 15.6%, and guidance raised after strong order intake.SMHN
Q2 20248 Jul 2026 - Record Q1 order intake drives optimism for 2026 despite weak sales and profit.SMHN
Q1 202613 May 2026 - Strong order intake and innovation drive ambitious growth and margin targets for 2030.SMHN
Investor presentation13 May 2026 - Record 2025 sales and new product launches support ambitious 2030 growth targets.SMHN
German Select VII Conference15 Apr 2026 - Record 2025 sales and strategic investments set the stage for double-digit growth through 2030.SMHN
Investor presentation13 Apr 2026 - Record 2025 sales of €503.2M; 2026 outlook signals lower sales and margins amid higher R&D.SMHN
Q4 20252 Apr 2026 - Record sales and EBIT growth offset by lower order intake and margin pressure, prompting guidance cuts.SMHN
Q2 202523 Nov 2025